Communicating about phase I trials: Objective disclosures are only a first step

Oncologist

Volumn 17, Issue 4, 2012, Pages 466-468

  Flamm, Anne Lederman ^a   Pentz, Rebecca D ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; EDITORIAL; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT INFORMATION; PATIENT PARTICIPATION; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; THERAPEUTIC MISCONCEPTION;

CLINICAL TRIALS AS TOPIC; HUMANS; PATIENT EDUCATION AS TOPIC;

EID: 84860158644     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2012-0107     Document Type: Editorial

References (27)

1. Fallowfield LJ, Solis-Trapala I, Jenkins VA. Evaluation of an educational program to improve communication with patients about early-phase trial participation. The Oncologist 2012;17:377-383.
2. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research. Int J Law Psychiatry 1982;5:319-329.
3. Emanuel EJ. A phase 1 trial on the ethics of phase 1 trials. J Clin Oncol 1995;13:1049-1051.
4. Miller M. Phase 1 cancer trials: A crucible of competing priorities. Int Anesthesiol Clin 2001;39: 13-33.
5. Annas G. Changing landscape of human experimentation: Nuremberg, Helsinki, and beyond. Health Matrix 1993;92:119.
6. Kodish E, Stocking C, Ratain MJ et al. Ethical issues in phase 1 oncology research: A comparison of investigators and institutional review board chairpersons. J Clin Oncol 1992;10:1810-1816.
7. Meropol NJ, Weinfurt KP, Burnett CB et al. Perceptions of patients and physicians regarding phase 1 cancer clinical trials: Implications for physicianpatient communication. J Clin Oncol 2003;21:2589-2596.
8. Daugherty C, Ratain MJ, Grochowski E et al. Perceptions of cancer patients and their physicians involved in phase 1 trials. J Clin Oncol 1995;13: 1062-1072.
9. Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: A medical oncology perspective. J Clin Oncol 1999; 17:1601-1617.
10. Joffe S, Cook EF, Cleary PD et al. Quality of informed consent: A new measure of understanding among research subjects. J Natl Cancer Inst 2001;93: 139-147.
11. Brown R, Bylund CL, Siminoff L et al. Seeking informed consent to phase I cancer clinical trials: Identifying oncologists' communication strategies. Psychooncol 2011;20:361-368.
12. Jenkins V, Solis-Trapala I, Langridge C et al. What oncologists believe they said and what patients believe they heard: An analysis of phase I trial discussions. J Clin Oncol 2011;29:61-68.
13. Baile WF, Aaron J. Patient-physician communication in oncology: Past, present, and future. Curr Opin Oncol 2005;17:331-335.
14. Baile WF, Lenzi R, Kudelka AP et al. Improving physician-patient communication in cancer care: Outcome of a workshop for oncologists. J Cancer Educ 1997;12:166-173.
15. Baile WF, Kudelka AP, Beale EA et al. Communication skills training in oncology: Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness. Cancer 1999;86:887-897.
16. Von Roenn JH, von Gunten C. The care people need and the education of physicians. J Clin Oncol 2011;29:4742-4743.
17. Breuer B, Fleishman SB, Cruciani RA et al. Medical oncologists' attitudes and practice in cancer pain management: A national survey. J Clin Oncol 2011;29:4769-4775.
18. von Gunten CF. Arrogance ignorance paradox. J Palliat Med 2005;8:898-899.
19. Shaeffer MH, Krantz DS, Wichman A et al. The impact of disease severity on the informed consent process in clinical research. Am J Med 1996;100: 261-268.
20. Horng S, Grady C. Misunderstanding in clinical research: Therapeutic misconception, therapeutic misestimation and therapeutic optimism. IRB 2003; 25:11-16.
21. Decoster G, Stein G, Holdener EE. Responses and toxic deaths in phase I clinical trials. Ann Oncol 1990;1:175-181.
22. Roberts TG Jr, Goulart BH, Squitieri L et al. Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 2004;292:2130-2140.
23. Weinfurt KP, Seils DM, Tzeng JP et al. Expectations of benefit in early-phase clinical trials: Implication for assessing the adequacy of informed consent. Med Decis Making 2008;28:575-581.
24. Cohen L, de Moor C, Amato RJ. The association between treatment-specific optimism and depressive symptomatology in patients enrolled in a phase I cancer clinical trial. Cancer 2001;91:1949-1955.
25. Jansen LA, Appelbaum PS, Klein WM et al. Unrealistic optimism in early-phase oncology trials. IRB 2011;33:1-8.
26. Pentz RD, White M, Harvey RD et al. Therapeutic misconception, misestimation and optimism in participants enrolled in phase 1 trials, Cancer 2012 Jan 31 [Epub ahead of print]. doi: 10.1002/cncr.27397.
27. Kohara I, Inoue T. Searching for a way to live to the end: Decision-making process in patients considering participation in cancer phase I clinical trials. Oncol Nurs Forum 2010;37:E124-E132.